Ocugen Inc (NASDAQ: OCGN) on Tuesday, soared 1.72% from the previous trading day, before settling in for the closing price of $0.84. Within the past 52 weeks, OCGN’s price has moved between $0.51 and $1.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -15.00%. With a float of $286.77 million, this company’s outstanding shares have now reached $292.03 million.
The extent of productivity of a business whose workforce counts for 95 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -1261.43%, and the pretax margin is -1271.12%.
Ocugen Inc (OCGN) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ocugen Inc is 1.80%, while institutional ownership is 26.40%. The most recent insider transaction that took place on Nov 26 ’24, was worth 9,095. In this transaction Director of this company bought 10,000 shares at a rate of $0.91, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director bought 25,000 for $0.91, making the entire transaction worth $22,848. This insider now owns 75,000 shares in total.
Ocugen Inc (OCGN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -15.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.87% during the next five years compared to 32.82% growth over the previous five years of trading.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Ocugen Inc (OCGN) is currently performing well based on its current performance indicators. A quick ratio of 2.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
The latest stats from [Ocugen Inc, OCGN] show that its last 5-days average volume of 4.37 million was superior to 4.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 34.93%. Additionally, its Average True Range was 0.08.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 68.00%, which indicates a significant increase from 57.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.35% in the past 14 days, which was lower than the 82.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7338, while its 200-day Moving Average is $0.8520. Now, the first resistance to watch is $0.8704. This is followed by the second major resistance level at $0.8892. The third major resistance level sits at $0.9194. If the price goes on to break the first support level at $0.8214, it is likely to go to the next support level at $0.7912. Assuming the price breaks the second support level, the third support level stands at $0.7724.
Ocugen Inc (NASDAQ: OCGN) Key Stats
Market capitalization of the company is 248.70 million based on 292,031K outstanding shares. Right now, sales total 4,060 K and income totals -54,050 K. The company made 1,480 K in profit during its latest quarter, and -15,350 K in sales during its previous quarter.
